错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

De novo posttransplant membranous nephropathy after COVID-19 vaccination 9 years after renal transplantation in a patient with polycystic kidney disease

  • Miruzato Fukuda,
  • Takayoshi Yokoyama,
  • Katsuyuki Miki,
  • Masayuki Yamanouchi,
  • Daisuke Ikuma,
  • Hiroki Mizuno,
  • Yuki Oba,
  • Noriko Inoue,
  • Akinari Sekine,
  • Kiho Tanaka,
  • Eiko Hasegawa,
  • Tatsuya Suwabe,
  • Takehiko Wada,
  • Kei Kono,
  • Keiichi Kinowaki,
  • Kenichi Ohashi,
  • Yutaka Yamaguchi,
  • Yuki Nakamura,
  • Yasuo Ishii,
  • Naoki Sawa,
  • Yoshifumi Ubara

摘要

A 63-year-old man with polycystic kidney disease underwent kidney transplantation from his wife. Nine years later, after the first and second doses of the COVID-19 vaccination, he developed proteinuria, hematuria, and elevated C-reactive protein. Kidney biopsy 7 months after the initial appearance of proteinuria showed immunoglobulin (Ig)-G granular stain, predominantly IgG1, and spike formation in the glomerular basement membrane. Electron microscopy revealed mainly subepithelial deposits, which corresponds to membranous nephropathy (MN) stage 3 of the Ehrenreich–Churg classification indicating chronic disease, but it also showed electron-dense deposits and endothelial damage. Because a kidney biopsy was performed 1 h after renal transplantation and a biopsy of the patient’s native kidney showed intact glomeruli, atypical de novo posttransplant membranous nephropathy (MN) was diagnosed, and a close relationship with COVID-19 vaccination was assumed. Clinicians should consider the involvement of COVID-19 vaccination in de novo posttransplant MN with unclear pathogenesis.